|
| |
BioJournal -
BioInformatics Gene 2 Drugs
http://www.bioportfolio.com/cgi-bin/acatalog/BioInformatics_gene2drug.html
 |
Positioning is how a brand appears in relation to other brands in the
market. It is influenced by the experiences customers have with a brand’s
products, services, advertising and promotional material, and
representatives over time. Using advanced statistical analysis this study,
consisting of six separate reports, will examine brand positioning in six
life science product categories: • Cell biology kits and reagents
• Gene expression analysis products• Instrumentation for genomic analysis
• Instrumentation for protein analysis• Nucleic acid purification
products
• Protein separation products |
|
|
Positioning is how a brand appears in relation to other brands in the
market. It is influenced by the experiences customers have with a brand’s
products, services, advertising and promotional material, and
representatives over time. Using advanced statistical analysis this report
will examine brand positioning in the cell biology kits and reagents
category. |
|
|
Positioning is how a brand appears in relation to other brands in the
market. It is influenced by the experiences customers have with a brand’s
products, services, advertising and promotional material, and
representatives over time. Using advanced statistical analysis this report
will examine brand positioning in the instrumentation for genomic analysis
category. |
|
|
Positioning is how a brand appears in relation to other brands in the
market. It is influenced by the experiences customers have with a brand’s
products, services, advertising and promotional material, and
representatives over time. Using advanced statistical analysis this report
will examine brand positioning in nucleic acid purification products. |
|
|
Positioning is how a brand appears in relation to other brands in the
market. It is influenced by the experiences customers have with a brand’s
products, services, advertising and promotional material, and
representatives over time. Using advanced statistical analysis this report
will examine brand positioning in protein separation products. |
 |
To build enduring loyalty, life science suppliers must constantly exceed
customer expectations. Customer Satisfaction & Loyalty in the Life Sciences:
Boosting Profit Through Exceptional Service & Support examines in detail
what elements of customer service and technical support influence the
customer's experience and drive customer satisfaction and loyalty. This
report will enable suppliers to better understand the needs of life science
customers for technical support and customer service. The data is presented
in a way that supports cross-departmental decision making, including
Marketing, Sales, Customer Service and Technical Support. |
 |
Life science suppliers were among the first companies in any industry to
grasp the commercial potential of the Web and some leading companies are now
receiving up to 40% of their orders online. Many companies, however, have
found that simply launching an electronic catalog and shopping cart are not
enough to generate online purchases, so this report probes the technological
and organizational challenges associated with eCommerce. Specifically, the
report examines the critical elements of a successful eCommerce strategy
from developing the optimal mix of relevant content to scientists’ need for
easy access to product information, pricing, convenient ordering and
technical support. |
 |
For this report -- a BioInformatics exclusive -- we polled nearly 1,000
life scientists so that you can equip your sale force with insider knowledge
to give them an edge in the increasingly dynamic and competitive life
science research market. |
 |
The Chinese social environment for the protection of intellectual
property right is complex. The locally produced generics and copy products
dominate the Chinese drug market. It is estimated that about 97 percent of
the drugs produced by local companies are generics or counterfeits. Facing
such complex social environment and market, most overseas and multinational
pharmaceutical companies fear that their imported drugs and pharmaceuticals
produced in China will be imitated or copied, in turn, their intellectual
property will be infringed and benefit will be violated. What reason
incurred such fear of overseas and multinational pharmaceutical companies?
Why did Eli Lilly & Company fail in its litigation of patent infringement
dispute case in China? Why can Pfizer win in an administrative proceeding
against the Patent Reexamination Board of the China State Intellectual
Property Office (SIPO) for its Viagra patent? Lack of knowledge of the
Chinese intellectual property right system and legislation institution, the
cultural difference between China and Western countries as well as the
language barriers incurred such result. |
|
|
In China, the development of biopharmaceutical industry is later
andbehind the developed countries. Just for this reason, the requirements of
materials and clinical trials for registration application of
biopharmaceuticals stipulated by the Chinese pharmaceutical authority are
far from systematic and uniform. The SFDA (State Food and Drug
Administration, China) divided the biopharmaceuticals for registration
application into two classifications, that is the therapeutic biological
products and the prophylactic biological products. However, in the
classification of therapeutic biological products, the SFDA does not provide
the uniform requirements of materials and clinical trials for application of
biological products for the gene therapy, the somatic cell therapy and the
allergic therapy, but stipulates the other guidelines for them. These
guidelines provide only a common principle for themrespectively because of
their diversity and complexity. |
|
|
In China, like in other Western countries, the pharmaceutical authority
-- the SFDA -- requests applicant to submit complicate and reliable
materials for application of drug registration. The SFDA stipulated the
classification of drug registration in order to administer the application
of chemical drug registration. At the same time, the SFDA collected the
materials for application of chemical drug registration into four categories
and 32 items in accordance with various chemical drug categories. When an
application of chemical drug registration is filed, the SFDA will request
applicant to not only submit designated material items in accordance with
prescribed category of chemical drug to apply for registration, but also
conduct the clinical trials for certain categorical chemical drugs. |
|
|
In China, the process of application and approval for imported drug
registration is very complex, because the Chinese pharmaceutical authorities
administer and control this process by exorbitant administrative measures
and regulations, moreover, these exorbitant administrative regulations are
variable and lack of transparency. Therefore, a comprehensive knowledge of
the Chinese latest regulations for imported drug registration has been
become an essential prerequisite for overseas pharmaceutical manufacturers
and producers to achieve a successful application for their products entry
into the Chinese drug market. |
|
|
The traditional medicines in Orient, especially, the traditional Chinese
medicines are always regarded by occidental as mysterious medicines. Until
today not only the chemical composition of traditional Chinese medicines
almost can not been expressed by a precise chemical structural formula, but
also the indications of the majority of traditional Chinese medicines still
can not been clearly described by the modern medical terminologies. How the
Chinese pharmaceutical authorities to administer the registration
application for such mysterious traditional Chinese medicines? This is the
third guidebook of the China Pharmaceutical Guidebook Series. It will
provide a detailed introduction of the Chinese pharmaceutical authorities’
requirements for materials and clinical trials of application and approval
for imported traditional Chinese medicine. The Chinese pharmaceutical
authorities collect the traditional Chinese medicines and the natural
medicines into a category for registration application. Therefore, this
guidebook will provide not only the introduction for registration
application of imported traditional Chinese medicines but for the natural
medicines. |
 |
This report examines how life scientists use various e-marketing tools
to receive information on the products and/or services related to their
research. It also evaluates the effectiveness of these e-marketing tools on
a supplier-specific basis. |
 |
RNA interference (RNAi) has rapidly evolved into a powerful technique to
silence gene expression in cells allowing researchers to study the molecular
effects of modulating expression at the level of individual genes. The
diversity of its applications has made RNAi an indispensable tool for both
academic and industrial scientists interested in gene function
characterization, signaling pathway analysis, and target validation. |
 |
Marketing to Life Scientists 2006: Capitalizing on Media Engagement
provides insights into the media preferences of life scientists and also
identifies suppliers considered to be best-in-class in each of six major
marketing media -- print catalogs, Web sites, direct mail, sales
representatives, print advertising, and scientific meetings and exhibits.
Most importantly, this report identifies a segment of life scientists who
are Highly Engaged with the marketing communication of their suppliers and
provides strategic insight into marketing to this potentially lucrative
group. |
 |
Biodefense research represents one of the fastest growing markets for
life science suppliers. Billions of dollars are being invested to support
basic research on potential agents of bioterrorism as well as the
development of vaccines, diagnostic tests and therapies to detect and
counter the effects of a bioterrorist attack. Despite this investment,
relatively few tools and techniques are specifically designed for biodefense
research, often leaving researchers to adapt products and methodologies
currently designed for other uses. |
 |
Oligonucleotides (oligos) represent an important market for life science
suppliers because they are an indispensable and ubiquitous tool for
scientists working with DNA and/or RNA. As the overall market for oligos is
considered mature, suppliers are challenged to distinguish their brand from
the many others available to scientists. To help suppliers meet this
challenge, we present the opinions of over 700 scientists who use oligos in
their research, including what they expect from their oligos and which
suppliers they buy from for their different research applications. |
 |
Customer Loyalty & Satisfaction: Creating a Branded Customer Experience
addresses the importance of brand, customer service and product attributes
to a customer's level of satisfaction and loyalty. In addition to providing
an overview of customer loyalty and satisfaction in the life science market
as a whole, this report provides detailed profiles of 24 top suppliers |
 |
Since the late 1970s, flow cytometry has enabled scientists to analyze a
variety of cell types. Today, the applications of this technology are even
more broad reaching and powerful. Through optical means, flow cytometers
distinguish cells on the basis of size and shape and on the basis of
molecules inside and on the surface of cells. Some scientists think about
flow cytometry as a “black box”, while others can easily operate the most
sophisticated of cytometers. Yet, nearly all scientists appreciate that flow
cytometry provides a lot of information about one’s sample in a relatively
short period of time. Given that scientists are at various levels of
sophistication—and have differing experimental needs when it comes to this
versatile technology—how can suppliers best secure and expand their market
share? |
 |
With over 325 commercial suppliers of antibodies, selecting just the
right antibody company brings to mind the famous lock and key analogy of
antibody-antigen binding—how do scientists find the perfect match?
BioInformatics LLC surveyed nearly 1,000 life scientists worldwide about the
types of catalog antibodies that they use and their opinions of commercial
suppliers. |
 |
In a crowded life science market, lists of advantages and product
features are no longer sufficient to differentiate one company’s offerings
from another’s. How does a supplier capture potential customers’ attention
and ensure that scientists develop a positive impression of its brand? A
strong corporate brand can have a halo effect on a company’s products across
market segments, generating excitement and a premium on that company’s goods
and services. Brands that can establish an emotional connection with
customers benefit from the luxury of “earning” time with scientists to make
a rational, persuasive case for buying their products. Without this close
bond, however, a corporation’s product brands can get lost in the multitude
of companies vying for scientists’ attention. |
 |
With nearly one hundred different types of DNA molecular weight markers
available from over 20 suppliers, ensuring that one’s products are
successful in the market is a challenging endeavor. Given that this product
has the potential to produce a constant revenue stream for suppliers because
of high profit margins, suppliers must constantly search for ways to ensure
that scientists buy their brand DNA molecular weight markers -- and not
their competitors' brand. |
 |
The Strategic Importance of the Reverse Transcriptase Market
If the increased use of gene expression technology for a broader set of
applications is any indication, reverse
transcriptase (RT) ranks with taq polymerase and restriction enzymes as one
of the most essential enzymes in a life scientist’s toolkit. From a product
strategy perspective, reverse transcriptase is all the more critical because
it
serves as an entry point into a supplier’s profitable kits and reagents (as
well as instrumentation) for the RT-PCR and real-time PCR markets. Dominance
in such an important market foothold can secure a key competitive advantage
for a supplier. However worthwhile, attaining and maintaining such a
position in the reverse transcriptase market is difficult due to the
presence of several key players. An effective competitive strategy requires
a thorough and nuanced understanding of market dynamics that this report is
designed to provide. |
 |
It is difficult to imagine life in the lab today without the benefit of
restriction enzymes. Because they are so ubiquitous, these tools have become
indispensable to many scientists even at the same time that they are often
taken for granted. Nonetheless, restriction enzymes support many
quintessential molecular biology applications including cloning, genotyping,
mutation analysis and sequencing. |
 |
Even though advertising is a critical and expensive marketing effort, it
is estimated that as much as half of all advertising campaigns are
ineffective. To help improve the success of your company’s advertising
efforts, this report offers insights into ad placement based upon your
customers’—the scientists—perspectives. |
http://www.bioportfolio.com/cgi-bin/acatalog/sitemap.html
| |
|
